Orphan nuclear receptor NR4A1 (Nur77)

Orphan nuclear receptor NR4A1 (Nur77) is a member of the nuclear hormone receptor superfamily that acts as a constitutively active, ligand-independent transcription factor[1][2][5]. It contains highly conserved DNA-binding and ligand-binding domains and is classified as an "orphan" receptor because natural endogenous ligands are not well defined[1][5]. Nur77 is rapidly induced as an immediate early gene in response to diverse stimuli such as stress, cytokines, and mitogenic signals[5]. It functions as a regulator of gene expression by binding specific response elements (NBRE) and forming heterodimers with retinoid X receptors (RXRs)[2][3]. While originally thought to be ligand-independent, several synthetic and natural compounds—including cytosporone B, THPN, celastrol, and bis-indole derivatives—have been identified as modulators or agonists[2][5]. Nur77 has central roles in regulating apoptosis, autophagy, immune responses, inflammation, hypoxia response, and cellular proliferation[2][4][6]. Its dysregulation has been implicated in cancer (as both a promoter and suppressor depending on context), inflammatory diseases, metabolic and cardiovascular disorders, and neurodegeneration[2][5][4]. Nur77 remains a promising but challenging therapeutic target due to its pleiotropic actions and the absence of well-defined endogenous ligands[5][2][3].

Other names

Nur77TR3NGFI-BNR4A1N10TIS1GFRP1

Ligand-dependent or ligand-independent modulation of transcriptional activity; Disruption or formation of heterodimers with retinoid X receptors (RXRs); Regulation of mitogenic and stress-responsive gene expression; Agonist-induced translocation and regulation of mitochondrial cell death pathways